Recruiting Geographic Atrophy Studies in Milwaukee
About Geographic Atrophy Clinical Trials in Milwaukee
Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.
There are currently 8 geographic atrophy clinical trials recruiting participants in Milwaukee, WI. These studies are seeking a combined 936 participants. Research is being sponsored by Medical College of Wisconsin, Johns Hopkins Bloomberg School of Public Health, OncoTherapy Science, Inc. and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Geographic Atrophy Clinical Trials in Milwaukee — FAQ
Are there geographic atrophy clinical trials in Milwaukee?
Yes, there are 8 geographic atrophy clinical trials currently recruiting in Milwaukee, WI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Milwaukee?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Milwaukee research site will contact you about next steps.
Are clinical trials in Milwaukee free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Milwaukee studies also compensate for your time and travel.
What geographic atrophy treatments are being tested?
The 8 active trials in Milwaukee are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.
Data updated October 16, 2026 from ClinicalTrials.gov